The value of bedside cardiac multibiomarker assay in rapid and accurate diagnosis of acute coronary syndromes.
For emergency department physicians, timely triage and risk stratification of chest pain patients remains a challenge. Faced with an aging population and the growing prevalence of heart disease, clinicians are seeking more effective ways to diagnose acute coronary syndromes rapidly and accurately. Emergency department physicians must make critical and time-sensitive decisions based on patient history, physical examination, and 12-lead electrocardiogram as justification for diagnosis of acute coronary syndromes. But because most of these tools are not reliable independently, these incomplete strategies can result in costly and inappropriate treatment decisions.
Dadkhah
Shahriar
S
Saint Francis Hospital, Evanston, Illinois 60202, USA. dadkhahsc@aol.com
Sharain
Korosh
K
Sharain
Roza
R
Kiabayan
Hamid
H
Foschi
Alberto
A
Zonia
Carolynn
C
Huettl
Brian
B
French
Scott
S
Gray
Elizabeth
E
Venkatachalam
Sridhar
S
Hegazy
Housam
H
Aldinger
Glenn
G
D000789:Angina, Unstable / Q000097:blood / Q000175:diagnosis*; D015415:Biomarkers / Q000097:blood; D052279:Creatine Kinase, MB Form / Q000097:blood; D003937:Diagnosis, Differential; D004636:Emergency Service, Hospital; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis*; D009211:Myoglobin / Q000097:blood; D020097:Natriuretic Peptide, Brain / Q000097:blood; D012680:Sensitivity and Specificity; D014218:Triage; D019210:Troponin I / Q000097:blood
D015415:Biomarkers; D009211:Myoglobin; D019210:Troponin I; D020097:Natriuretic Peptide, Brain; D052279:Creatine Kinase, MB Form